⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026

NSE

Abbott India LimitedABBOTINDIA

ABBOTINDIA₹25,955 0.42% today
Nifty Midcap 150

Abbott India is the listed Indian arm of Abbott, focused on branded pharma.

Key productsBranded formulations across GI, metabolics, women's health and CNS.
GeographyIndia.
CompetitorsSun Pharma, USV, Mankind.

AI-generated overview — verify before relying on it.

Net institutional flow

No institutional deals

Institutional buyers

0 in / 0 out

High-impact filings

0 · tilt Neutral

Next corporate action

Competitive landscape — the read

vs mapped peers · 3M
Institutional money is backing ALKEM hardest (+1,013.7 Cr net). ABBOTINDIA ranks #2 of 9 on flow (net buying +0 Cr). Filing momentum favours ZYDUSLIFE (+1). News & social buzz is most positive on DRREDDY.
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1ALKEM+1,013.7 Cr13-26
2ABBOTINDIAThis+217
3CIPLA+1944
4DRREDDY+2046
5SUNPHARMA+1545
6TORNTPHARM
7LUPIN
8ZYDUSLIFE1+1
9AUROPHARMA

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

SWOT

Strengths

  • [object Object]
  • [object Object]

Weaknesses

  • [object Object]
  • [object Object]

Opportunities

  • [object Object]
  • [object Object]

Threats

  • [object Object]
  • [object Object]

AI-generated from our data — verify before relying on it.

Timeline — ABBOTINDIA day by day

  1. 2026-06-15NewsAbbott India sets July 24 record date for ₹656 dividendTopic · India.
  2. 2026-05-25NewsAbbott India Limited Appoints Swati Pathak as Associate Director - Operations, Effective June 1, 202626Topic · India.
  3. 2026-05-13NewsAbbott India FY26 Results Published in Newspapers Under Regulation 47scanx.trade
  4. 2026-02-27NewsAbbott seals distribution pact with Novo to market Ozempic second brand in IndiaTopic · India.
  5. 2026-02-03NewsAbbott India Limited Schedules Board Meeting for February 12, 2026 to Review Q3FY26 Financial Resultsscanx.trade
  6. 2026-01-19NewsGetting In Cheap On Abbott India Limited (NSE:ABBOTINDIA) Is Unlikelysimplywall.st
  7. 2025-12-27NewsAbbott India announces key changes to its boardTopic · India.
  8. 2025-12-24NewsAbbott India Limited (NSE:ABBOTINDIA) stock most popular amongst public companies who own 75%, while individuasimplywall.st
  9. 2025-12-12NewsLupin Manufacturing Solutions and PolyPeptide Announce Strategic Alliance to Scale Global Peptide Supply ChainTopic · metabolics
  10. 2025-11-25NewsAbbott India appoints Vinutha Mufti as new Director, Business Human ResourcesTopic · India.
  11. 2025-11-24NewsAbbott India Limited's (NSE:ABBOTINDIA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Ssimplywall.st
  12. 2025-03-06NewsEris Lifesciences appoints Murari Ranganathan to spearhead Cardiometabolic BusinessTopic · metabolics
  13. 2025-02-28NewsAbbott India: Resignation of Sridhar Kadangode as CFO, Murari Ranganathan as Commercial Director -...Topic · metabolics
  14. 2025-01-03NewsAbbott India appoints Prithwish K Banerji as Commercial Director - Women’s Health, Metabolics and InternationaTopic · metabolics
  15. 2024-03-14NewsBiocon Biologics, Eris Lifesciences announce long-term collaboration to expand patient access to metabolics,..Topic · metabolics
  16. 2022-01-08NewsABBOTT INDIA SHARE PRICE TODAYICICI Direct
  17. 2020-04-27NewsICMR agreed to pay 2.5 times the price for rapid test kits, Delhi HC judgment showsTopic · metabolics

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

No scored filings for ABBOTINDIA yet.

Bulk & block deals

No bulk/block deals for ABBOTINDIA in this window.

News & chatter on ABBOTINDIA

RSS News

17
ABBOTT INDIA SHARE PRICE TODAY

ICICI Direct · 8/1/2022

Google News RSS — links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.